Consecinţele timpurii ale miopatiilor inflamatorii idiopatice
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
285 3
Ultima descărcare din IBN:
2019-06-11 13:08
Căutarea după subiecte
similare conform CZU
616.74-002-021.3 (1)
Patologia organelor de locomoţie. Sistemul osos şi locomotor (238)
SM ISO690:2012
LOGHIN-OPREA, Natalia; VETRILĂ, Snejana; MAZUR-NICORICI, Lucia; MAZUR, Minodora. Consecinţele timpurii ale miopatiilor inflamatorii idiopatice. In: Sănătate Publică, Economie şi Management în Medicină . 2017, nr. 3(73), pp. 143-145. ISSN 1729-8687.
EXPORT metadate:
Google Scholar
Crossref
CERIF
BibTeX
DataCite
Dublin Core
Sănătate Publică, Economie şi Management în Medicină
Numărul 3(73) / 2017 / ISSN 1729-8687

Consecinţele timpurii ale miopatiilor inflamatorii idiopatice

Early consequences of idiopathic infl ammatory myopathies


CZU: 616.74-002-021.3
Pag. 143-145

Loghin-Oprea Natalia, Vetrilă Snejana, Mazur-Nicorici Lucia, Mazur Minodora
 
Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“
 
Disponibil în IBN: 1 noiembrie 2017


Rezumat

Idiopathic inflammatory myopathies (IIM) are a group of rare diseases characterized by asthenia of skeletal muscles. Early approach to disease leads to a favorable evolution of the disease and less outcomes. The aim of this study is to assess the short-term outcomes in patients with IIM. We conducted a transversal study enrolling 12 patients (7 women, 5 men) with IIM, the mean age was 54.1±12.1 (30–67) years and the follow–up period was 16±9.4, (7-25) months. Patients were assessed by aplying specific questionnaires and modern, validated clinical tools.We found in all patients muscle damage manifested by muscular dysfunction – 11 (91.7%) patients and atrophy in one (8,3%) patient,  confirmed by moderate muscle strengh, which implies disability – 10 (83.3%) patients. Gastrointestinal damage was manifested by dysphagia in 3 (25.0%) patients, hepatic steatosis – 3 (25.0%), dismotility – 5 (41.7%) patients. Endocrine damage like dyslipidemia had 4 (33.3%), secondary amenorrhea – 4 (33.3%), diabetes mellitus in 2 (16.6%) patients. Despite moderate disease activity the most common disease outcomes obtained were muscular – 100% patients, gastrointestinal – 91.7% and endocrine – 83.3% patients